estimation of glutathione-s-transferase Full article: Automated approach for the evaluation glutathione-S- transferase P1-1 inhibition by organometallic anticancer compounds Assay for quantitative determination of
Description
Mertens et al., 2023)
A 12mg dose
W.HiganoC
The identification of the relationship between GPxs and breast cancer is valuable for the discovery of potential therapeutic targets for breast cancer
Even if reclassified, it will not be FDA-approved it will simply be eligible for legal compounding with a prescription
Patients should discuss potential risks, benefits, and alternatives with their healthcare providers before beginning any peptide therapy
